Telix Pharmaceuticals
(OTC) TLPPF
Telix Pharmaceuticals Financials at a Glance
Market Cap
$3.79B
Revenue (TTM)
A$2.01B
Net Income (TTM)
A$39.06M
EPS (TTM)
-$0.02
P/E Ratio
-529.38
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Price
$11.88
Volume
4,164
Open
$11.88
Price
$11.88
Volume
4,164
Open
$11.88
Previous Close
$11.88
Daily Range
$11.25 - $11.88
52-Week Range
$5.91 - $16.76
Estimated Earnings Date
Aug 20, 2026
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Price
$11.88
Volume
4,164
Open
$11.88
Previous Close
$11.88
Daily Range
$11.25 - $11.88
52-Week Range
$5.91 - $16.76
Estimated Earnings Date
Aug 20, 2026
TLPPF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Telix Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
1,184
CEO
Christian P. Behrenbruch, PhD, EMBA
Website
www.telixpharma.comHeadquarters
North Melbourne, VIC 3051, AU
TLPPF Financials
Key Financial Metrics (TTM)
Gross Margin
50.76%
Operating Margin
2.11%
Net Income Margin
-0.89%
Return on Equity
-1.72%
Return on Capital
2.08%
Return on Assets
-0.61%
Earnings Yield
-0.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.79B
Shares Outstanding
339.38M
Volume
4.16K
Avg. Volume
3.64K
Financials (TTM)
Gross Profit
A$1.13B
Operating Income
A$107.90M
EBITDA
A$155.40M
Operating Cash Flow
A$10.18M
Capital Expenditure
-A$84.29M
Free Cash Flow
-A$68.64M
Cash & ST Invst.
A$212.66M
Total Debt
A$699.77M
Telix Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$630.70M
+123.9%
Gross Profit
A$332.84M
+48.6%
Gross Margin
52.77%
N/A
Market Cap
$3.79B
N/A
Market Cap/Employee
$3.38M
N/A
Employees
1,120
N/A
Net Income
-A$7.37M
-137.7%
EBITDA
A$29.40M
+27.9%
Quarterly Fundamentals
Total Cash
A$212.66M
+72.6%
Total Debt
A$699.77M
+3911.3%
Accounts Receivable
A$207.42M
+220.2%
Inventory
A$55.58M
+221.1%
Long Term Debt
A$671.87M
+4129.3%
Short Term Debt
A$27.95M
+1692.9%
Return on Assets
-0.61%
N/A
Return on Invested Capital
1.81%
N/A
Free Cash Flow
-A$94.47M
-3426.4%
Operating Cash Flow
-A$54.35M
-611.5%